Evidence map›Paper›PMID 30675521›Full record

ArticleCommunications biology2019

MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex.

Yoshinori Abe, Yosuke Suzuki, Kenji Kawamura, Nobuyuki Tanaka

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Lysine and arginine methylation of transcription factors.Cellular and molecular life sciences : CMLS · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Protein arginine methylation in transcription and epigenetic regulation.Frontiers in epigenetics and epigenomics · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yoshinori AbeDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical School, Kosugi-cho 1-396, Nakahara-ku, Kawasaki, Kanagawa 211-8533 Japan.ORCID 0000-0003-3894-494X
Yosuke SuzukiDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical School, Kosugi-cho 1-396, Nakahara-ku, Kawasaki, Kanagawa 211-8533 Japan.
Kenji KawamuraDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical School, Kosugi-cho 1-396, Nakahara-ku, Kawasaki, Kanagawa 211-8533 Japan.
Nobuyuki TanakaDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical School, Kosugi-cho 1-396, Nakahara-ku, Kawasaki, Kanagawa 211-8533 Japan.
Nippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcription factor GLI1 is an effecter of Hedgehog (HH) signalling and activated in a broad spectrum of cancers. However, the role of the HH-GLI1 pathway in cancer and the activation mechanism of GLI1 in HH signalling after dissociation from its inhibitor, SUFU, are not fully understood. Here, we found that GLI1 associated with the methylosome protein 50 (MEP50)/protein arginine methyltransferase 5 (PRMT5) complex and was methylated. Association of MEP50/PRMT5 with GLI1 was enhanced and expression of MEP50 and PRMT5 was activated by HH signals, suggesting their role in positive feedback regulation. Methylated GLI1 lost its ability to bind ubiquitin ligase ITCH/NUMB, resulting in nuclear accumulation and activation of GLI1. Moreover, protein expression of GLI1 was enhanced by MEP50/PRMT5 and expression of MEP50, PRMT5, and GLI1 target genes was upregulated in HH-expressing cancers. These results suggest that MEP50/PRMT5 is important for HH signal-induced GLI1 activation, especially in cancers.

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingCell LineHedgehog ProteinsHumansMembrane ProteinsMethylationModels, BiologicalMultiprotein ComplexesNerve Tissue ProteinsProtein-Arginine N-MethyltransferasesProtein BindingRepressor ProteinsTranscription FactorsUbiquitinationUbiquitin-Protein LigasesAdaptor Proteins, Signal TransducingGLI1 protein, humanHedgehog ProteinsITCH protein, humanMembrane ProteinsMultiprotein ComplexesNerve Tissue ProteinsNUMB protein, humanPRMT5 protein, humanProtein-Arginine N-MethyltransferasesRepressor ProteinsTranscription FactorsUbiquitin-Protein LigasesWDR77 protein, humanZinc Finger Protein GLI1

Identifiers

PMID30675521
PMCPMC6338668
OpenAlexW2916726725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.